Aller au contenu principal
2025 article

Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy

5Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : ca. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

OBJECTIVE: To evaluate risk of severe hypoglycemia after total pancreatectomy (TP). BACKGROUND: Historically, TP was feared due to loss of insulin and counter-regulatory hormones, as well as the risk of severe hypoglycemic events (SHE). While TP with islet auto-transplant (TPIAT) can preserve endocrine function, past studies reported 41% SHE incidence post-operatively. Advancements in insulin therapies and continuous glucose monitors (CGMs) have likely improved outcomes but are understudied in this population. METHODS: This single center study analyzed TP patients from 2009-2024. CGMs (Dexcom G7) were provided for the study if patients did not have one. Demographics, survival, emergency department visits, and glycemic control were assessed. RESULTS: Among 147 TP cases, 76 underwent TP alone and 71 TPIAT. In the TP-alone patients, two deaths (2/76; 2.63%) occurred due to hypoglycemia. Pre-operatively, TP-alone patients had higher HbA1c (7.1±2.2%) than TPIAT patients (5.9±1.3%; P<0.001). In the first month post-operatively, TP-alone patients had higher HbA1c than TPIAT-insulin dependent patients, but no difference over 10 years. Hypo/hyperglycemia-related hospital visits, median time in target range (TP: 53.5%, IQR: 36.5-68.5 vs. TPIAT insulin-dependent: 59.0%, IQR: 43.3-67.5), and glycemic variability (coefficient of variation; 31.3%, IQR 28.3-35.0 vs 32.3%, IQR 28.7-35.5) were similar between TP-alone and TPIAT-insulin dependent groups. In 14 days of CGM capture, no severe hypoglycemia was observed in TP-alone patients (<3.0 mmol/L). CONCLUSIONS: Advancements in insulins and CGMs provide acceptable outcomes after TP without supplemental islet transplantation, and lower risk of SHE than previously reported. This encouraging data may aid surgical decision-making and patient selection for surgery.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy
Date Crossref
12/08/2025
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Hyperglycemia and glycemic control in critically ill and hospitalized patientsPancreatic function and diabetesPancreatic and Hepatic Oncology Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.